Skip to main content

MIT Corporate Relations

MIT Corporate Relations
MIT Logo
  • Read
  • Watch
  • Attend
  • About
  • Connect
  • MIT Startup Exchange
Search
  • Sign-In
  • Register
MIT ILP Home
  • Read
    • Faculty Features
    • Research
    • News
  • Watch
  • Attend
    • Conferences
    • Webinars
    • Learning Opportunities
  • About
    • Membership
    • Staff
    • For Faculty
  • Connect
    • Faculty/Researchers
    • Program Directors
  • MIT Startup Exchange
User Menu and Search
  • Sign-In
  • Register
MIT ILP Home
Toggle menu
  • Sign-in
  • Register
  • Read
    • Faculty Features
    • Research
    • News
  • Watch
  • Attend
    • Conferences
    • Webinars
    • Learning Opportunities
  • About
    • Membership
    • Staff
    • For Faculty
  • Connect
    • Faculty/Researchers
    • Program Directors
  • MIT Startup Exchange

Search Results


Filter Results
  • Show:
  • 10
  • 50
  • 100

Filter Results

Narrow your results
  • News (275)
  • Videos (417)
  • Events (134)
  • Research (1064)
  • Faculty (312)
  • Members (1)
2219 search results found
  • Innovation in Manufacturing Biomedicines: Stacy Springs

    January 24, 2024Conference Video Duration: 42:45

    Innovation in Manufacturing Biomedicines: From New Modalities to Scalable, Accessible Therapeutics
    Stacy Springs
    Executive Director, MIT Center for Biomedical Innovation (CBI)

    Biologic medicines (e.g., monoclonal antibodies, gene and cell therapies, vaccines) are critical to treating and preventing disease. Recent regulatory approvals of exciting new biomedicines such as cell and gene therapies provide new hope to patients who have exhausted alternative therapies or suffer from a rare disease with no other treatment. To help patients access these medicines, biopharmaceutical companies must be able to manufacture very complex molecules safely, reliably, and in the quantities needed, which can range from the very large (industrialized) scale to the very small (personalized) scale. This presentation will review the challenges in manufacturing these complex biologic medicines as well as approaches to modernization of biomanufacturing with the goal of providing broadened access to biologic medicines. Dr. Springs will describe multiple approaches that MIT’s  Center for Biomedical Innovation and collaborators are taking to achieve this goal, including continuous manufacturing, novel purification strategies, novel analytical technologies for assessing novel product quality attributes, and rapid methods for sterility and viral safety assessment.

  • SMR-Logo
    March 1, 2021

    To cut costs, know your customer

  • Manuel Ventero - 2018 ICT Conference

    April 11, 2018Conference Video Duration: 17:55

    Redefining Small Business Lending through ML and Social Physics

    SMEs are the backbone of most economies and employ approximately 60 percent of the working population in OECD countries. However, these businesses often struggle the most to access financing, oftentimes, relying on friends and family to help them flourish and thrive by lending money when others do not. We have created Trust·u to offer a solution to this. Trust·u is an internal venturing effort from BBVA, positioned to address innovation opportunities in an agile manner by mimicking startups. We utilize a digital platform to enable rapid on-boarding and underwriting, combining social elements with financial data, to grant small businesses access to financing based on a new risk assessment model, which takes full advantage of ML techniques and new data sources.

    Redefining Small Business Lending through ML and Social Physics. 

    2018 MIT Information and Communication Technologies Conference
  • Vivek
    A
    Bald

    Associate Professor of Writing and Digital Media
    Primary DLC
    Comparative Media Studies/Writing

    Contact

    MIT Room
    14N-435
    Phone
    (617) 452-5086
    vbald@mit.edu
  • December 15, 2006
    Department of Electrical Engineering and Computer Science

    Understanding the Information Processing in Biological Cells\n

    Principal Investigator Alan Oppenheim

  • December 15, 2006
    Department of Electrical Engineering and Computer Science

    Evolution of Biological Signalling Networks\n

    Principal Investigator Alan Oppenheim

  • December 15, 2006
    Department of Electrical Engineering and Computer Science

    New Algorithms Inspired by Biology\n

    Principal Investigator Alan Oppenheim

  • 6.30.23-Perth-Corporate-Reverse-Pitch

    June 30, 2023Conference Video Duration: 48:21
    Corporate Reverse Pitch 
  • 2021-RD-Jason-Jackson

    November 18, 2021Conference Video Duration: 28:22
    Jason Jackson
    Assistant Professor of Political Economy and Urban Planning
  • 2024 Decarbonization Webinar: Mutual Reinforcement of Land-based Carbon Dioxide Removal and International Emissions Trading in Deep Decarbonization Scenarios

    November 7, 2024Conference Video Duration: 48:16
    Mutual Reinforcement of Land-based Carbon Dioxide Removal and International Emissions Trading in Deep Decarbonization Scenarios
    Jennifer Morris
    Principal Research Scientist, MIT Joint Program on the Science and Policy of Global Change and the MIT Energy Initiative

    Achieving long-term climate stabilization targets that limit warming to 1.5oC or 2oC requires deep decarbonization, with total greenhouse gas (GHG) emissions eventually falling to net zero. Because some emissions in the economy are difficult to eliminate, most 1.5oC or 2oC pathways rely on negative emissions strategies to offset residual positive GHG emissions in hard-to-abate sectors. Among carbon dioxide removal (CDR) technologies, bioenergy with carbon capture and storage (BECCS) and natural-climate solutions such as afforestation and reforestation (A/R) are among the most widely considered options. The deployment of these options will depend on their availability as well as the climate policy regime, particularly the availability of international emissions trading. In fact, CDR and international trade in GHG permits mutually reinforce each other. This relationship and its implications for the scale of CDR and emissions trading, regional deployment, carbon prices, and GDP will be discussed in this talk.

Pagination

  • of 222
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • 221
  • 222
  • Next page

Sign up to receive news and updates from MIT Industrial Liaison Program Sign up

  • Read
    • Faculty Features
    • Research
    • News
  • Watch
  • Attend
    • Conferences
    • Webinars
    • Learning Opportunities
  • About
    • Membership
    • Staff
    • For Faculty
  • Connect
    • Faculty/Researchers
    • Program Directors
  • MIT Startup Exchange
  • LinkedIn
  • YouTube
  • Twitter
Home

1 Main Street
12th Floor, E90-1201

Cambridge, MA 02142

Privacy Policy

Accessibility

617-253-2691
ask-ilp@mit.edu

MIT OCR Logo